MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells.
Saved in:
| Title: | MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells. |
|---|---|
| Authors: | Zelceski A; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Francica P; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; Departement of Biomedical Research (DBMR), Cancer Therapy Resistance Cluster, University of Bern, 3012 Bern, Switzerland., Lingg L; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; Departement of Biomedical Research (DBMR), Cancer Therapy Resistance Cluster, University of Bern, 3012 Bern, Switzerland., Mutlu M; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland., Stok C; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Liptay M; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland., Alexander J; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Baxter JS; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Brough R; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Gulati A; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Haider S; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Raghunandan M; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Song F; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Sridhar S; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Forment JV; Oncology R&D, AstraZeneca, Cambridge, UK., O'Connor MJ; Oncology R&D, AstraZeneca, Cambridge, UK., Davies BR; Oncology R&D, AstraZeneca, Cambridge, UK., van Vugt MATM; Oncology R&D, AstraZeneca, Cambridge, UK., Krastev DB; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK., Pettitt SJ; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. Electronic address: Stephen.pettitt@icr.ac.uk., Tutt ANJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. Electronic address: Andrew.tutt@icr.ac.uk., Rottenberg S; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; Departement of Biomedical Research (DBMR), Cancer Therapy Resistance Cluster, University of Bern, 3012 Bern, Switzerland; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands; Bern Center for Precision Medicine, University of Bern, 3012 Bern, Switzerland. Electronic address: sven.rottenberg@vetsuisse.unibe.ch., Lord CJ; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. Electronic address: Chris.lord@icr.ac.uk. |
| Source: | Cell reports [Cell Rep] 2023 May 30; Vol. 42 (5), pp. 112484. Date of Electronic Publication: 2023 May 09. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37163373 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zelceski+A%22">Zelceski A</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Francica+P%22">Francica P</searchLink>; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; Departement of Biomedical Research (DBMR), Cancer Therapy Resistance Cluster, University of Bern, 3012 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lingg+L%22">Lingg L</searchLink>; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; Departement of Biomedical Research (DBMR), Cancer Therapy Resistance Cluster, University of Bern, 3012 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mutlu+M%22">Mutlu M</searchLink>; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stok+C%22">Stok C</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Liptay+M%22">Liptay M</searchLink>; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Alexander+J%22">Alexander J</searchLink>; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Baxter+JS%22">Baxter JS</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Brough+R%22">Brough R</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Gulati+A%22">Gulati A</searchLink>; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Haider+S%22">Haider S</searchLink>; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Raghunandan+M%22">Raghunandan M</searchLink>; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Song+F%22">Song F</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Sridhar+S%22">Sridhar S</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Forment+JV%22">Forment JV</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22O'Connor+MJ%22">O'Connor MJ</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Davies+BR%22">Davies BR</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22van+Vugt+MATM%22">van Vugt MATM</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Krastev+DB%22">Krastev DB</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Pettitt+SJ%22">Pettitt SJ</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. Electronic address: Stephen.pettitt@icr.ac.uk.<br /><searchLink fieldCode="AU" term="%22Tutt+ANJ%22">Tutt ANJ</searchLink>; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. Electronic address: Andrew.tutt@icr.ac.uk.<br /><searchLink fieldCode="AU" term="%22Rottenberg+S%22">Rottenberg S</searchLink>; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland; Departement of Biomedical Research (DBMR), Cancer Therapy Resistance Cluster, University of Bern, 3012 Bern, Switzerland; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands; Bern Center for Precision Medicine, University of Bern, 3012 Bern, Switzerland. Electronic address: sven.rottenberg@vetsuisse.unibe.ch.<br /><searchLink fieldCode="AU" term="%22Lord+CJ%22">Lord CJ</searchLink>; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London SW3 6JB, UK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. Electronic address: Chris.lord@icr.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101573691%22">Cell reports</searchLink> [Cell Rep] 2023 May 30; Vol. 42 (5), pp. 112484. <i>Date of Electronic Publication: </i>2023 May 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101573691 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-1247 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37163373 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.celrep.2023.112484 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 112484 Titles: – TitleFull: MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zelceski A – PersonEntity: Name: NameFull: Francica P – PersonEntity: Name: NameFull: Lingg L – PersonEntity: Name: NameFull: Mutlu M – PersonEntity: Name: NameFull: Stok C – PersonEntity: Name: NameFull: Liptay M – PersonEntity: Name: NameFull: Alexander J – PersonEntity: Name: NameFull: Baxter JS – PersonEntity: Name: NameFull: Brough R – PersonEntity: Name: NameFull: Gulati A – PersonEntity: Name: NameFull: Haider S – PersonEntity: Name: NameFull: Raghunandan M – PersonEntity: Name: NameFull: Song F – PersonEntity: Name: NameFull: Sridhar S – PersonEntity: Name: NameFull: Forment JV – PersonEntity: Name: NameFull: O'Connor MJ – PersonEntity: Name: NameFull: Davies BR – PersonEntity: Name: NameFull: van Vugt MATM – PersonEntity: Name: NameFull: Krastev DB – PersonEntity: Name: NameFull: Pettitt SJ – PersonEntity: Name: NameFull: Tutt ANJ – PersonEntity: Name: NameFull: Rottenberg S – PersonEntity: Name: NameFull: Lord CJ IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 05 Text: 2023 May 30 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2211-1247 Numbering: – Type: volume Value: 42 – Type: issue Value: 5 Titles: – TitleFull: Cell reports Type: main |
| ResultId | 1 |